Here, we reported several pathways, such as those of sphingolipids, VEGFA, C-type lectin receptor, and MAPK, that are important in the progression of NAFLD and could be modulated by Calebin-A. The gene discussed is CLEC4D; the disease is metabolic dysfunction-associated steatotic liver disease.